GF Fund Management’s Travere Therapeutics TVTX Stock Holding History
Bought
Maintained
Sold
Other funds holding TVTX
GF Fund Management's TVTX Position: Q3 2026 in Review
GF Fund Management increased its Travere Therapeutics (TVTX) stake by 8.8% in Q3 2026, buying an estimated $10.6K and bringing the position to 2,128 shares worth $125K. The position accounts for ﹤0.01% of the portfolio, ranked #319.
GF Fund Management first reported a position in TVTX in Q4 2024 and has held it in 8 quarters since. 345 funds tracked by Wall St. Rank hold TVTX as of Q3 2026.
- GF Fund Management held 2,128 shares of Travere Therapeutics worth $125K as of Q3 2026.
- GF Fund Management bought 173 Travere Therapeutics shares in Q3 2026, an estimated $10.6K.
- Travere Therapeutics made up ﹤0.01% of GF Fund Management's portfolio in Q3 2026, its #319 holding.
- GF Fund Management first reported a position in Travere Therapeutics in Q4 2024 and has held it in 8 quarters since.
- 345 funds tracked by Wall St. Rank held Travere Therapeutics as of Q3 2026.
Based on GF Fund Management's 13F filing for Q3 2026, filed 26 Oct 2026.